Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients

Early Phase 1CompletedNCT00337038

Soroka University Medical Center50 enrolled

Overview

Our aim is to examine the influence of blood pressure and glycemic control together with N-acetylcystein utilization on the endothelia function of hypertensive diabetic patient.The study population will include 50 diabetic patient with uncontrolled hypertention that will be recruited from the Hypertension Clinic of Soroka University Medical Center.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Hypertension Diabetes Mellitus Type 2

Interventions

N-acetylcystein(drug)DRUG

p.O t.Siran 200mg x1 during one weak

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetic patients with uncontrolled hypertension that will be recruited from the Hypertension Clinic of Soroka University Medical Center Exclusion Criteria: * Pregnancy,secondary hypertention,malignancy or other serious illness

Outcomes

Primary Outcomes

endothelial function

Time frame: half of year

Secondary Outcomes

blood pressure and glycemic control

Time frame: half of year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.